Aeterna Zentaris’ AEZS-130 demonstrates potential as oral diagnostic test for AGHD Aeterna Zentaris Inc. The info was presented previous today by Beverly M.K. Biller, M.D. Of the Harvard Medical School/Massachusetts General Medical center in Boston, at the 5th International Congress of the GROWTH HORMONES Research Culture and the Insulin-like Growth Elements Society in New York City. AEZS-130 offers been granted Orphan Medication Designation by the Food and Medication Administration as a diagnostic test for AGHD.The types of fat a person eats make a difference what types of lipids are present in your body. Unexpectedly, the authors found the obese people got higher levels of certain types of lipids made up of polyunsaturated fatty acids in their adipose cells than did their non-obese twins. This finding is usually interesting because cell membranes are primarily composed of lipids, and different lipids can transform a membrane’s physical properties, such as for example fluidity. When the authors utilized computers to model the effect of these different lipids on adipose cell membranes, they discovered that the new lipids seen in the cells of the obese twins balanced each other in such a way that general membrane fluidity was unaffected.